Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Revaccination in Healthy Adolescents
NCT04152161Phase 2Terminated
- Sponsor
- Gates Medical Research Institute
- Start
- Oct 2019
- Primary completion
- May 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in Tuberculosis (TB), sponsored by Gates Medical Research Institute. Started Oct 2019; status: terminated.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04152161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04152161.